191 related articles for article (PubMed ID: 22609637)
1. Occupational solvent exposure, genetic variation in immune genes, and the risk for non-Hodgkin lymphoma.
Deng Q; Zheng T; Lan Q; Lan Y; Holford T; Chen Y; Dai M; Leaderer B; Boyle P; Chanock SJ; Rothman N; Zhang Y
Eur J Cancer Prev; 2013 Jan; 22(1):77-82. PubMed ID: 22609637
[TBL] [Abstract][Full Text] [Related]
2. Occupational solvent exposure, genetic variation of DNA repair genes, and the risk of non-Hodgkin's lymphoma.
Jiao J; Zheng T; Lan Q; Chen Y; Deng Q; Bi X; Kim C; Holford T; Leaderer B; Boyle P; Ba Y; Xia Z; Chanock SJ; Rothman N; Zhang Y
Eur J Cancer Prev; 2012 Nov; 21(6):580-4. PubMed ID: 22430443
[TBL] [Abstract][Full Text] [Related]
3. Genetic variation in metabolic genes, occupational solvent exposure, and risk of non-hodgkin lymphoma.
Barry KH; Zhang Y; Lan Q; Zahm SH; Holford TR; Leaderer B; Boyle P; Hosgood HD; Chanock S; Yeager M; Rothman N; Zheng T
Am J Epidemiol; 2011 Feb; 173(4):404-13. PubMed ID: 21228414
[TBL] [Abstract][Full Text] [Related]
4. Occupational exposure to solvents and risk of non-Hodgkin lymphoma in Connecticut women.
Wang R; Zhang Y; Lan Q; Holford TR; Leaderer B; Zahm SH; Boyle P; Dosemeci M; Rothman N; Zhu Y; Qin Q; Zheng T
Am J Epidemiol; 2009 Jan; 169(2):176-85. PubMed ID: 19056833
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms in DNA repair genes, hair dye use, and the risk of non-Hodgkin lymphoma.
Guo H; Bassig BA; Lan Q; Zhu Y; Zhang Y; Holford TR; Leaderer B; Boyle P; Qin Q; Zhu C; Li N; Rothman N; Zheng T
Cancer Causes Control; 2014 Oct; 25(10):1261-70. PubMed ID: 25178586
[TBL] [Abstract][Full Text] [Related]
6. Immune mechanisms in non-Hodgkin lymphoma: joint effects of the TNF G308A and IL10 T3575A polymorphisms with non-Hodgkin lymphoma risk factors.
Wang SS; Cozen W; Cerhan JR; Colt JS; Morton LM; Engels EA; Davis S; Severson RK; Rothman N; Chanock SJ; Hartge P
Cancer Res; 2007 May; 67(10):5042-54. PubMed ID: 17510437
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms in pattern-recognition genes in the innate immunity system and risk of non-Hodgkin lymphoma.
Hu W; Bassig BA; Xu J; Zheng T; Zhang Y; Berndt SI; Holford TR; Hosgood HD; Leaderer B; Yeager M; Menashe I; Boyle P; Zou K; Zhu Y; Chanock S; Lan Q; Rothman N
Environ Mol Mutagen; 2013 Jan; 54(1):72-7. PubMed ID: 23055202
[TBL] [Abstract][Full Text] [Related]
8. Occupational exposure to solvents and risk of lymphoma subtypes: results from the Epilymph case-control study.
Cocco P; t'Mannetje A; Fadda D; Melis M; Becker N; de Sanjosé S; Foretova L; Mareckova J; Staines A; Kleefeld S; Maynadié M; Nieters A; Brennan P; Boffetta P
Occup Environ Med; 2010 May; 67(5):341-7. PubMed ID: 20447988
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms in immune function genes and risk of non-Hodgkin lymphoma: findings from the New South Wales non-Hodgkin Lymphoma Study.
Purdue MP; Lan Q; Kricker A; Grulich AE; Vajdic CM; Turner J; Whitby D; Chanock S; Rothman N; Armstrong BK
Carcinogenesis; 2007 Mar; 28(3):704-12. PubMed ID: 17056605
[TBL] [Abstract][Full Text] [Related]
10. Genetic variation in tumor necrosis factor and the nuclear factor-kappaB canonical pathway and risk of non-Hodgkin's lymphoma.
Cerhan JR; Liu-Mares W; Fredericksen ZS; Novak AJ; Cunningham JM; Kay NE; Dogan A; Liebow M; Wang AH; Call TG; Habermann TM; Ansell SM; Slager SL
Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3161-9. PubMed ID: 18990758
[TBL] [Abstract][Full Text] [Related]
11. Genetic variation in chromosomal translocation breakpoint and immune function genes and risk of non-Hodgkin lymphoma.
Fernberg P; Chang ET; Duvefelt K; Hjalgrim H; Eloranta S; Sørensen KM; Porwit A; Humphreys K; Melbye M; Ekström Smedby K
Cancer Causes Control; 2010 May; 21(5):759-69. PubMed ID: 20087644
[TBL] [Abstract][Full Text] [Related]
12. Personal and occupational exposure to organic solvents and risk of non-Hodgkin's lymphoma (NHL) in women (United States).
Kato I; Koenig KL; Watanabe-Meserve H; Baptiste MS; Lillquist PP; Frizzera G; Burke JS; Moseson M; Shore RE
Cancer Causes Control; 2005 Dec; 16(10):1215-24. PubMed ID: 16215872
[TBL] [Abstract][Full Text] [Related]
13. Association with TP53 codon 72 polymorphism and the risk of non-Hodgkin lymphoma.
Kim HN; Yu L; Kim NY; Lee IK; Kim YK; Yang DH; Lee JJ; Shin MH; Park KS; Choi JS; Kim HJ
Am J Hematol; 2010 Oct; 85(10):822-4. PubMed ID: 20734458
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms in DNA repair pathway genes, body mass index, and risk of non-Hodgkin lymphoma.
Chen Y; Zheng T; Lan Q; Kim C; Qin Q; Foss F; Chen X; Holford T; Leaderer B; Boyle P; Wang C; Dai M; Liu Z; Ma S; Chanock SJ; Rothman N; Zhang Y
Am J Hematol; 2013 Jul; 88(7):606-11. PubMed ID: 23619945
[TBL] [Abstract][Full Text] [Related]
15. Solvent exposure and non-Hodgkin lymphoma: no risk in a population-based study in the San Francisco Bay Area.
Tranah GJ; Holly EA; Bracci PM
Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):3130-2. PubMed ID: 19900943
[TBL] [Abstract][Full Text] [Related]
16. Associations of non-Hodgkin Lymphoma (NHL) risk with autoimmune conditions according to putative NHL loci.
Wang SS; Vajdic CM; Linet MS; Slager SL; Voutsinas J; Nieters A; de Sanjose S; Cozen W; Alarcón GS; Martinez-Maza O; Brown EE; Bracci PM; Lightfoot T; Turner J; Hjalgrim H; Spinelli JJ; Zheng T; Morton LM; Birmann BM; Flowers CR; Paltiel O; Becker N; Holly EA; Kane E; Weisenburger D; Maynadie M; Cocco P; Foretova L; Staines A; Davis S; Severson R; Cerhan JR; Breen EC; Lan Q; Brooks-Wilson A; De Roos AJ; Smith MT; Roman E; Boffetta P; Kricker A; Zhang Y; Skibola C; Chanock SJ; Rothman N; Benavente Y; Hartge P; Smedby KE
Am J Epidemiol; 2015 Mar; 181(6):406-21. PubMed ID: 25713336
[TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphisms in nitric oxide synthase genes modify the relationship between vegetable and fruit intake and risk of non-Hodgkin lymphoma.
Han X; Zheng T; Lan Q; Zhang Y; Kilfoy BA; Qin Q; Rothman N; Zahm SH; Holford TR; Leaderer B; Zhang Y
Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1429-38. PubMed ID: 19423521
[TBL] [Abstract][Full Text] [Related]
18. C677T and A1298C polymorphisms of methylene tetrahydrofolate reductase in non-Hodgkin lymphoma: southeast Iran.
Mashhadi MA; Miri-Moghaddam E; Arbabi N; Bazi A; Heidari Z; Sepehri Z; Karimkoshte A; Rezvan A; Hashemi SM
Tumori; 2018 Aug; 104(4):280-284. PubMed ID: 28430351
[TBL] [Abstract][Full Text] [Related]
19. Cytokine polymorphisms in Th1/Th2 pathway genes, body mass index, and risk of non-Hodgkin lymphoma.
Chen Y; Zheng T; Lan Q; Foss F; Kim C; Chen X; Dai M; Li Y; Holford T; Leaderer B; Boyle P; Chanock SJ; Rothman N; Zhang Y
Blood; 2011 Jan; 117(2):585-90. PubMed ID: 20952689
[TBL] [Abstract][Full Text] [Related]
20. Genetic variation in H2AFX contributes to risk of non-Hodgkin lymphoma.
Novik KL; Spinelli JJ; Macarthur AC; Shumansky K; Sipahimalani P; Leach S; Lai A; Connors JM; Gascoyne RD; Gallagher RP; Brooks-Wilson AR
Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1098-106. PubMed ID: 17548670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
